Patrick Aisher
Limited Partner @ MedScience Ventures
Patrick Aisher is a British-Austrian businessman who attended University in Montreal and London. He is Chairman of Kinled Holding Ltd in HK, which owns shares in a portfolio of more than 30 technology and medical companies. Mr. Aisher is a member of the Swiss Corporate Finance and Private Equity Association & the Swiss Finance and TechnologyAssociation. He directs Kinled Life Sciences Ventures Ltd, and is a Limited Partner in Concentric Team Technology I LP and MedScience Ventures LLC. He is also Director of a UK Charity that supports the under-privileged and unwell.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 20%
Last updated:
For AI agents: llms.txt
Industries Patrick Aisher invests in
Stages Patrick Aisher invests in
Countries Patrick Aisher invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $1.3M–$10M
Investment Focus
Industry
- Health Care 2 (40%)
- Medical Device 2 (40%)
- SaaS 1 (20%)
- FinTech 1 (20%)
- Finance 1 (20%)
Stage
- Seed 2 (40%)
- Series B 2 (40%)
- Pre-Seed 1 (20%)
Country
- Switzerland 2 (40%)
- Austria 1 (20%)
- Finland 1 (20%)
- United Kingdom 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Cornea Sense
|
CorneaSense is a medtech startup developing a non-invasive, eye-based sensing device that measures ocular surface hydration to enable early detection and monitoring of conditions such as dry eye disease and systemic health disorders. The technology aims to provide real-time, objective eye biomarkers for improved clinical diagnosis and patient care. | $1.3M / Pre-Seed / Jul 13, 2026 | |
Linxfour - Transforming Equipment Finance
|
Linxfour is a European leasing company, based in Austria, providing Pay-per-Use financing solutions to manufacturing companies. Using proprietary IIoT (Industrial Internet of Things) technology and AI-driven risk management, we are unique in underwriting true utilisation risk. Operating across over 26 different countries and industries, we arecommitted to helping businesses finance equipment with our unparalleled solution. | Series B / Sep 19, 2023 | |
Unaric
|
Unaric buys, builds and grows Salesforce based SaaS companies and is backed by leading global investors. | $10M / Seed / Jun 28, 2023 | |
PreComb
|
PreComb develops technologies to optimally adapt the therapies to each patient for difficult to treat cancers to increase the success rates in cancer therapy. Only an efficient use of healthcare resources can lead to a maximum improvement in the quality of life of patients. | $1.3M / Seed / Oct 04, 2022 | |
KB Medical
|
KB Medical is a Swiss company focusing on design, development, and commercialization of the AQrate robotic system for assisting surgeons during the spinal surgery. Its AQrate robotic system’s technology and intellectual property empowers spinal surgeons with precise, cost-effective, robotic-assisted spinal fusion in a less hazardous workenvironment.KB Medical improves patients’ outcome and quality of life after a spinal fusion surgery as well as to reduce the received radiation by the OR team during the surgery. It is certified for the design and manufacture of assisted robotic system for spinal surgery accordingly to ISO 13485.KB Medical is based in Ecublens, Switzerland. | $2.5M / Series B / Oct 25, 2016 |
Co-Investors
About MedScience Ventures
MedScience Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Patrick Aisher
Limited Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Patrick Aisher invest in?
Patrick Aisher invests primarily in Health Care, Medical Device and SaaS startups, most often at Seed and Series B stage. Most of the 5 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Patrick Aisher's check size?
Patrick Aisher typically joins rounds of $1.3M–$10M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Patrick Aisher participates in.
How do I contact Patrick Aisher?
Public channels for Patrick Aisher include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Patrick Aisher last invest?
The most recent investment recorded for Patrick Aisher closed in Jul 2026. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
